PT  - JOURNAL ARTICLE
AU  - van Duijn, Shannen
AU  - Barsosio, Hellen C.
AU  - Omollo, Mevis
AU  - Milimo, Emmanuel
AU  - Akoth, Isdorah
AU  - Aroka, Robert
AU  - de Sanctis, Teresa
AU  - K’Oloo, Alloys
AU  - June, Micah J.
AU  - Houben, Nathalie
AU  - Wilming, Charlotte
AU  - Otieno, Kephas
AU  - Kariuki, Simon
AU  - Onsongo, Simon
AU  - Odhiambo, Albert
AU  - Ganda, Gregory
AU  - de Wit, Tobias F. Rinke
TI  - Public-private partnership to strengthening COVID-19 response in Kisumu, Kenya
AID  - 10.1101/2021.08.31.21262891
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.08.31.21262891
4099  - http://medrxiv.org/content/early/2021/12/13/2021.08.31.21262891.short
4100  - http://medrxiv.org/content/early/2021/12/13/2021.08.31.21262891.full
AB  - INTRODUCTION In Kenya approximately half of healthcare services are delivered through private sector providers. In line with our experience building rapid responses to HIV and to support and accelerate the public sector’s COVID-19 response, we initiated a PPP project in Kisumu County, Kenya. In this manuscript we demonstrate this PPP’s performance using digital tools as a replicable model for scaling the response to COVID-19 in similar resource-poor settings.METHODS COVID-19 diagnostic testing formed the basis for a PPP between KEMRI, Department of Health Kisumu County, PharmAccess Foundation, and local faith-based and private healthcare facilities, thus naming our PPP: COVID-Dx. COVID-Dx was implemented from June 01, 2020, to March 31, 2021, in Kisumu County, Kenya. Trained laboratory technologists in participating healthcare facilities collected nasopharyngeal and oropharyngeal samples from patients meeting the Kenyan MoH COVID-19 case definition. Samples were tested using RT-PCR at the central reference laboratory in KEMRI. Healthcare workers in participating facilities collected patient clinical data using a digitized MoH COVID-19 Case Identification Form. We shared aggregated results from these data via (semi-) live dashboard to all relevant stakeholders. We did descriptive statistical analyses using Stata 16 to inform project processes.Results Nine facilities participated in the project. A detailed collaboration schedule was developed, supported by a semi-real time digital dashboard. A total of 4,324 PCR tests for SARS-CoV-2 were added to the public response, with 425 positives. Geo-mapped and time-tagged information on incident cases was collected and fed back to policymakers. At the beginning of the pandemic, there a heavy focus on health workers within Kisumu County, with a total of 1009 tested consisting about 43% of all County health workforce.CONCLUSION We demonstrate feasibility to rapidly increase the public health sector response to a COVID-19 epidemic outbreak in a resource-poor setting. Our complementary public-private intervention in Kisumu, Kenya was based on a joint testing strategy and demonstrated that digitalization of the healthcare system can gain efficiencies, link public and private healthcare efforts, increase transparency and inform local policy makers with semi-real time data supporting targeting interventions. The Kisumu model is currently being scaled to 13 additional western Kenyan counties.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was financially supported by Achmea Foundation, Pfizer Foundation, and the Netherlands Ministry of Foreign Affairs. Grant/Award numbers for all funders: N/A. The funders did not have any role in study design, data collection, analysis, interpretation, summarizing the data or decision to submit the manuscript for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical clearance for this project was obtained from Jaramogi Oginga Odinga Teaching & Referral Hospital (JOOTRH) on June 16, 2020, with approval number IERC/JOOTRH/230/2020. KEMRI also provided ethical clearance on September 30, 2020, with approval number KEMRI KEMRI/SERU/CGHR/05-05/4038. Research License was obtained from the National Commission for Science, Technology, and Innovation (NACOSTI) on July 6, 2020 (NACOSTI/P/20/5616). The roll-out of this project was in complete coordination with the Kisumu Department of Health. Sample collection in patients in this project was voluntary.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to the privacy of patient data, datasets associated with this project are not publicly available. Anonymized and aggregated data are available from the authors upon request.CCIFCOVID Case Identification FormCOVAXCOVID-19 Global Vaccine AccessCOVID-19coronavirus disease of 2019DoHDepartment of HealthGDPRGeneral Data Protection RegulationGFATMThe Global Fund to Fight AIDS, Tuberculosis and MalariaHIPAAHealth Insurance Portability and Accountability Act of 1996KEMRIKenya Medical Research InstituteLMIClow-and middle-income countriesMoHMinistry of HealthNGOnon-governmental organizationPCRpolymerase chain reactionPEPFARPresident’s Emergency Plan for AIDS ReliefPPEpersonal protective equipmentPPPpublic-private partnershipRDTrapid diagnostic testRNARibonucleic acidToTtrainers of trainersUHCuniversal health coverageVTMviral transport mediumWHOWorld Health Organization